What Does Mutational Status Indicate About CLL Disease Risk? Jeff Sharman, MD, Michael Choi, MD, Andrew Schorr
How Can CLL Patients Talk to Their Doctors About Clinical Trials? Jeanne Schaffer, RN, Jeff Sharman, MD, Jeffrey Menashe, MD
Does Participating in a CLL Trial Preclude Me From Other Treatments? Jeanne Schaffer, RN, Michael Choi, MD, Jeff Sharman, MD, Andrew Schorr
Why Watch and Wait? Understanding CLL Disease Development Jeffrey Menashe, MD, Michael Choi, MD, Andrew Schorr
What CLL Diagnostic Info Is Valuable Before Making Treatment Decisions? Jeffrey Menashe, MD, Jeff Sharman, MD, Andrew Schorr
